Association between transillumination breast spectroscopy and quantitative mammographic features of the breast

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 5, 2008, Pages 1043-1050

  Blackmore, Kristina M ^a   Knight, Julia A ^a   Lilge, Lothar ^b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; LIPID; WATER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; FEMALE; HUMAN; ILLUMINATION; LIGHT SCATTERING; LINEAR REGRESSION ANALYSIS; MAMMOGRAPHY; MENOPAUSE; PREMENOPAUSE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SCORING SYSTEM; SPECTROSCOPY; TRANSILLUMINATION BREAST SPECTROSCOPY; BREAST TUMOR; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY; STATISTICAL MODEL;

ADULT; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; LINEAR MODELS; MAMMOGRAPHY; MIDDLE AGED; TRANSILLUMINATION;

EID: 52649158790     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2658     Document Type: Article

References (44)

1. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6:798-808.
2. Boyd NF, O'Sullivan B, Campbell JE, et al. Mammographic signs as risk factors for breast cancer. Br J Cancer 1982;45:185-93.
3. Bryson J, Merletti F, Sadowsky NL. Mammographic features of the breast and breast cancer risk. Am J Epidemiol 1982;115:428-37.
4. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. Am J Roentgenol 1987;148:1087-92.
5. Saftlas AF, Hoover RN, Brinton LA, et al. Mammographic densities and risk of breast cancer. Cancer 1991;67:2833-8.
6. Oza AM, Boyd NF. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev 1993;15:196-208.
7. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-5.
8. Boyd NF, Lockwood GA, Byng J, Tritchler DL, Yaffe M. Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:1133-44.
9. Yaffe MJ, Boyd NF, Byng JW, et al. Breast cancer risk and measured mammographic density. Eur J Cancer Prev 1998;7:S47-55.
10. Vacek PM, Geller BM. A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev 2004;13:715-21.
11. Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic density: relationship with breast cancer risk. Radiology 2004;230:29-41.
12. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN. Mammographic density and breast cancer risk: the Multiethnic Cohort Study. Am J Epidemiol 2005;162:743-52.
13. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.
14. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227-36.
15. Yaffe M, Boyd N. Mammographic breast density and cancer risk: the radiological view. Gynecol Endocrinol 2005;21:6-11.
16. Torres-Mejia G, De Satvola B, Allen DS, et al. Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev 2005;14:1052-9.
17. Kato I, Beinhart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer. Cancer Causes Control 1995;6:431-8.
18. Boyd NF, Greenburg C, Lockwood G, et al. Effect at two years of a low fat, high carbohydrate diet on radiologic features of the breast: results from a randomized trial. J Natl Cancer Inst 1997;89:488-96.
19. Knight JA, Martin LJ, Greenberg CV, et al. Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiol Biomarkers Prev 1999;8:123-8.
20. Simick M. Near infrared transillumination spectroscopy of breast tissue for correlation with mammographic density. Master's thesis, Department of Medical Biophysics, University of Toronto; 2002.
21. Simick M. Jong R, Wilson B, Lilge L. Non-ionizing near-infrared radiation transillumination spectroscopy for breast tissue density and assessment of breast cancer risk. J Biomed Opt 2004;9:794-803.
22. Blyschak K, Simick M, Jong R, Lilge L. Classification of breast tissue density by optical transillumination spectroscopy: optical and physiological effects governing predictive value. Med Phys 2004;31:1398-414.
23. Blackmore KM, Knight JA, Jong R, Lilge L. Assessing breast tissue density by transillumination breast spectroscopy (TIBS): an intermediate indicator of cancer risk. Br J Radiol 2007;80:545-56.
24. Peters VG, Wyman DR, Patterson MS, Frank GL. Optical properties of normal and diseased human breast tissues in the visible and near infrared. Phys Med Biol 1990;35:1317-34.
25. Key H, Davies ER, Jackson PC, Wells PN. Optical attenuation characteristics of breast tissues at visible and near-infrared wavelengths. Phys Med Biol 1991;36:579-90.
26. Tromberg BJ, Coquoz O, Fishkin JB, et al. Non-invasive measurements of breast tissue optical properties using frequency-domain photon migration. Philos Trans R Soc Lond B Biol Sci 1997;352:661-8.
27. Quaresima V, Matcher SJ, Ferrari M. Identification and quantification of intrinsic optical contrast for near-infrared mammography. Photochem Photobiol 1998;67:4-14.
28. Cerussi AE, Berger AJ, Bevilacqua F, et al. Sources of absorption and scattering contrast for near-infrared optical mammography. Acad Radiol 2001;8:211-8.
29. Shah N, Cerussi A, Eker C, et al. Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci U S A 2001;98:4420-5.
30. Durduran T, Choe R, Culver JP, et al. Bulk optical properties of healthy female breast tissue. Phys Med Biol 2002;47:2847-61.
31. Srinivasan S, Pogue B, Jiang S, et al. Interpreting hemoglobin and water concentration, oxygen saturation and scattering measured in vivo by near infrared breast tomography. Proc Natl Acad Sci U S A 2003;100:12349-54.
32. Graham SJ, Bronskill MJ, Byng JW, Yaffe MJ, Boyd NF. Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. Br J Cancer 1996;73:162-8.
33. Lee NA, Rusinek H, Weinreb J, et al. Fatty and fibroglandular tissue volumes in the breasts of women 20-83 years old: comparison of X-ray mammography and computer-assisted MR imaging. Am J Radiol 1997;168:501-6.
34. Wise BM. PLS tool box tutorial: MatLab version 6. Seattle (WA): Eigenvector Research; 2000.
35. Byng JW, Yaffe MJ, Lockwood GA, Little LE, Trichtler DL, Boyd NF. Automated analysis of mammographic densities and breast carcinoma risk. Cancer 1997;80:66-74.
36. Boyd NF, Lockwood GA, Byng JW, Little LE, Yaffe MJ, Tritchler DL. The relationship between anthropometrics measures to radiological features of the breast in premenopausal women. Br J Cancer 1998;78:1233-8.
37. Boyd NF, Martin L, Stone J, Little L, Minkin S, Yaffe M. A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev 2002;11:1048-53.
38. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. "Hormonal risk factors," "breast tissue age" and the age-incidence of breast cancer. Nature 1983;303:767-70.
39. Guo XP, Martin LJ, Hanna W, et al. Growth factors and stromal matrix protein associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 2001;10:243-8.
40. Alowami S, Troup S, Al-Haddad S, Kitlepatrick I, Watson PM. Mammographic density is related to stroma and stromal proteolysis expression. Breast Cancer Res 2003;5:R129-35.
41. Boyd NF, Martin LJ, Sum L, et al. 2006. Body size, mammographic density and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2006;15:2086-92.
42. Ursin G, Parisky YR, Pike MC, Spicer DV. Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 2001;10:141-2.
43. Buist DSM, Aiello EJ, Miglioretti DL, White E. Mammographic breast density, dense area, breast area differences by phase in menstrual cycle. Cancer Epidemiol Biomarkers Prev 2006;15:2303-6.
44. White E, Velentgas P, Mandelson MT, et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40 to 49 years. J Natl Cancer Inst 1998;90:906-10.